[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:bipolar-ii-disorder":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":79,"states":80},"Bipolar II Disorder",11,9,[8,16,22,28,35,40,46,53,59,65,72],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06696755","A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder",[12],"Phase 2","RECRUITING","2026-08-26T02:18:51.833592Z","2026-07-19T19:36:05.036523Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07220460","Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder",[12],"2026-08-26T02:16:42.787115Z","2026-07-05T05:32:16.663718Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT06188754","Healthy Lifestyles for Bipolar Disorder",[],"2026-08-26T02:16:28.221034Z","2026-05-05T02:43:29.321590Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":33,"content_modified":34},"NCT07172516","A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",[32],"Phase 3","2026-08-26T02:18:31.944757Z","2026-05-05T02:43:27.486966Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":20,"content_modified":39},"NCT07127913","Closed-Loop Deep Brain Stimulation for Treatment-Resistant Bipolar Depression",[],"2026-05-05T02:43:26.979421Z",{"nct_id":41,"title":42,"phases":43,"status":13,"updated_at":44,"content_modified":45},"NCT05699226","Amplitude Titration to Improve ECT Clinical Outcomes",[],"2026-08-26T02:15:27.567165Z","2026-04-29T02:57:57.062383Z",{"nct_id":47,"title":48,"phases":49,"status":13,"updated_at":51,"content_modified":52},"NCT07213466","Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder",[50],"Phase 4","2026-08-26T02:17:02.694423Z","2026-05-05T02:43:27.833235Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT06706232","Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality",[12],"2026-08-26T02:16:54.876240Z","2026-04-29T02:57:57.087287Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":63,"content_modified":64},"NCT07622927","FOCUS Bipolar: Families Opening Conversations for Understanding Signs",[],"2026-08-26T02:18:55.570428Z","2026-06-05T00:55:50.389735Z",{"nct_id":66,"title":67,"phases":68,"status":69,"updated_at":70,"content_modified":71},"NCT00762866","Psychiatric Genotype\u002FPhenotype Project Repository",[],"ENROLLING_BY_INVITATION","2026-08-26T02:15:24.145250Z","2026-06-16T05:54:07.944547Z",{"nct_id":73,"title":74,"phases":75,"status":76,"updated_at":77,"content_modified":78},"NCT05849402","Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolar II Disorder",[],"ACTIVE_NOT_RECRUITING","2026-08-03T03:25:11.951163Z","2026-05-05T02:43:28.290093Z",[],[81,85,89,93,96,99,102,105,108],{"state":82,"count":83,"slug":84},"California",6,"california",{"state":86,"count":87,"slug":88},"Texas",5,"texas",{"state":90,"count":91,"slug":92},"Arizona",3,"arizona",{"state":94,"count":91,"slug":95},"Florida","florida",{"state":97,"count":91,"slug":98},"Georgia","georgia",{"state":100,"count":91,"slug":101},"Illinois","illinois",{"state":103,"count":91,"slug":104},"Missouri","missouri",{"state":106,"count":91,"slug":107},"New York","new-york",{"state":109,"count":91,"slug":110},"Washington","washington"]